WCG adds clinical trial benchmarking firms to portfolio

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Kritchanut)
(Image: Getty/Kritchanut)

Related tags: WCG, Benchmarking, Clinical trials, CRO, Contract research organization, Contract research

WCG’s acquisition of KMR Group and MCC addresses sponsor and CRO need to establish a common set of metrics to understand and manage clinical trial performance, says CEO.

KMR Group and Metrics Champion Consortium (MCC) will operate independently as part of the WIRB-Copernicus Group (WCG) Market Insights and Intelligence Division. The firms provide benchmarking, metrics, analytics and performance management in the clinical research and development space.

WCG will support the companies with access to capital, expertise, and corporate operational support, according to the clinical services organization.

“The sheer volume of clinical trial performance data available to sponsors and CROs has exploded over the past few years and many clinical trial leaders are struggling to operationalize these data in a consistent and actionable manner,”​ said Donald A. Deieso, PhD, executive chairman and CEO of WCG.

To keep up, Deieso told us “sponsors and CROs need to establish a common set of metrics to understand and manage clinical trial performance.”

“By bringing together these leading companies, we can address the growing need to establish standardized data benchmarks across the most critical areas of R&D and clinical trial execution.”

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars